In brief
Purdue Pharma has reached a new $7.4 billion settlement with the Sackler family, a deal designed to compensate victims of the opioid crisis and promote recovery efforts.
Purdue Pharma and the Sackler family have made a significant decision, agreeing to a settlement of up to $7.4 billion (£6 billion) regarding the contentious OxyContin prescription painkiller, which has been pivotal in escalating America's opioid crisis. This new settlement marks an increase of over $1 billion compared to a previous agreement that was rejected by the US Supreme Court in 2024, as reported by AP and Reuters.Under the stipulated terms, the Sackler family will contribute up to $6.5 billion, while Purdue will be responsible for an additional $900 million. OxyContin, linked to numerous addiction cases and fatalities, has been criticized for being a gateway drug to more potent narcotics, like heroin, resulting in a devastating opioid epidemic affecting countless lives across the country. Purdue expressed satisfaction with the new settlement in a statement, indicating that it aims to compensate affected victims and facilitate the delivery of life-saving treatments and overdose rescue medications.Although the settlement requires court approval, it remains one of the most monumental settlements arising from various lawsuits aimed at holding pharmaceutical companies accountable for the opioid crisis. Under former President Donald Trump's administration, the federal government is reportedly not expected to contest this agreement. Connecticut Attorney General William Tong stated that this settlement could provide essential closure to the victims of the opioid epidemic, emphasizing that true justice cannot be measured solely by monetary compensation.Since the introduction of OxyContin in 1999, opioid overdose deaths in the U.S. have surged dramatically, with tens of thousands succumbing annually. Court documents indicate that the Sackler family was likely aware of the potential legal ramifications and had withdrawn around $11 billion from the company prior to its bankruptcy, with much of these funds allegedly stashed overseas. This complicated the process of recovering funds to assist victims and combat the crisis effectively.




